SCHEMBL2166883

SCHEMBL2166883

[CH2]CCC1NCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032175 0.79 CDK1 (0.35)
SCHEMBL8662458 0.78
SCHEMBL19474284 0.75
SCHEMBL7741975 0.73
SCHEMBL6797745 0.73
SCHEMBL5050328 0.73
SCHEMBL4025607 0.73
SCHEMBL3647422 0.73
SCHEMBL13785217 0.72 PRCP (0.50)
SCHEMBL3652550 0.72 CYP1A2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603998-B2 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-12-10 US disclosed
EP-2217611-B1 NOVEL MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS MERCK SHARP & DOHME (US) 2013-07-31 EP disclosed
US-20110183933-A1 NOVEL MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS MERCK SHARP & DOHME LLC 2011-07-28 US disclosed